Keil TW, Feldmann DP, Costabile G, Zhong Q, da Rocha S, Merkel OM
Novo Nordisk recently pulled out of a $10 billion bidding war with Pfizer for Metsera arguably an attempt to regain dominance in the lucrative obesity drug market through acquisition of further weight loss drug brands even though the treatments from Metsera could still be years away from hitting shelves
Whats more, the visceral fat around your organs releases signals that raise low-grade inflammation and make insulin less effective, setting up a vicious cycle: Less muscle and more visceral fat leads to more inflammation, worse insulin sensitivity, and easier fat gain around the middle
Included in the meta-analysis were 45 research articles that fulfilled the search criteria
Medications like Ozempic and Mounjaro/Zepbound are injected subcutaneously either into the stomach or thigh